Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Finding The Value In Shifting R&D Models

This article was originally published in The Pink Sheet Daily

Executive Summary

Consultancy McKinsey & Co. is optimistic about the future of R&D within the pharma industry, but says certain aspects of the organizations need to shift – making the companies leaner and more productive – to maintain the industry’s leadership position.

Advertisement

Related Content

Deals Of The Week’s Takeaway From PSA: Optimism With Aches
Building A Fully Integrated Biotech Company: What It Takes

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS076289

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel